Home > Insider Trading > Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc. (ARWR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
51 - 57

Arrowhead Research Corp (ARWR): Bridger Management Builds 5.5% Passive Stake

Roberto Mignone’s Bridger Management has amassed a 5.5% stake in Arrowhead Research Corp (NASDAQ:ARWR) according to a 13G filing with the Securities and Exchange Commission on January 23.

Keep Reading →

January 26th, 2015 - Hedge Funds News

Arrowhead Research Corp (ARWR), ValueVision Media Inc (VVTV): QVT Financial and Cannell Capital Disclose Their Latest Moves

In two recent filings with the Securities and Exchange Commission, Daniel Gold's QVT Financial and J. Carlo Cannell's Cannell Capital revealed raising stakes in two of their holdings.

Keep Reading →

October 14th, 2014 - Hedge Funds News

A 6-Pack of Hedge Fund Moves to Take Note Of

There are over 8,000 hedge funds in existence today, but just an elite group is worth paying attention to.

Keep Reading →

October 21st, 2013 - Hedge Funds News

Daniel Gold's Hedge Fund is 3rd in a Week to Buy Arrowhead Research Stock

Daniel Gold, Arrowhead Research: In a filing with the Securities and Exchange Commission, Daniel Gold's QVT Financial reported ownership of some 2.05 million shares of Arrowhead Research Corp (NASDAQ...

Keep Reading →

October 21st, 2013 - Hedge Funds News

7 Hedge Fund Trades to Keep an Eye On

Tiger Global Management reported ownership of some 53.5 million shares of London-listed BBA Aviation plc (LON:BBA).

Keep Reading →

October 17th, 2013 - Hedge Funds News

Ridgeback Capital Follows Steven Cohen Into Arrowhead Research

Ridgeback Capital, Arrowhead Research: A couple of minutes ago, Wayne Holman's Ridgeback Capital Management disclosed ownership of over 1.8 million shares of Arrowhead Research Corp (NASDAQ:ARWR), which...

Keep Reading →

October 16th, 2013 - Hedge Funds News

Steven Cohen Takes a Big Position in Arrowhead Research

SAC Capital, Cohen, Arrowhead Research: Steven Cohen's SAC Capital just disclosed a 5.2% passive stake in Arrowhead Research Corp (NASDAQ:ARWR), a bio-therapeutics company that specializes in nanomedicine...

Keep Reading →

October 15th, 2013 - Hedge Funds News